siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways.

Biomedicines · 2018 · PMC6164725 · PMID 29932151

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, combined delivery of the siRNAs targeting both ER and BCL2 siRNAs showed a trend of further declining the tumor mass, particularly at the earlier stage of the experimental period. 3.6.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.